TEVJF News and Press, Teva Pharmaceutical Industries Ltd

2024-06-11 11:41:04 ET Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference Call June 11, 2024, 08:00 AM ET Company Participants Richard Francis - President & Chief Executive Officer Conference Call Participants ...

2024-06-07 10:57:58 ET Summary Since Richard Francis became CEO in early 2023, his 'Pivot to Growth' strategy has continued to bear fruit. On April 16, the FDA approved Selarsdi, a biosimilar of Stelara, which earned Johnson & Johnson about $2.45 billion in the first quarter o...

2024-05-21 06:53:48 ET Summary Abrams' 13F portfolio value decreased from $3.22B to $3.20B this quarter. The number of holdings in the portfolio decreased from 14 to 12. The top three stakes in the portfolio make up approximately 48% of the total, while the top five holdings m...

2024-05-14 14:35:08 ET Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference May 14, 2024, 11:40 AM ET Company Participants Jason Gerberry - Managing Director, US Specialty Pharma and Smid Cap Biotech Richard Francis - President &a...

2024-05-08 11:32:14 ET Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Conference Call May 08, 2024, 08:00 AM ET Company Participants Ran Meir - Head, Investor Relations Richard Francis - Chief Executive Officer Eric Hughes - Head, R&D & Ch...

2024-04-24 07:15:00 ET Summary Sound Shore Fund, Inc. is registered as a diversified, open-end management investment company. The investment objective of the Fund is growth of capital. The Sound Shore Fund Investor Class and Institutional Class advanced 17.05% and 17.10%, respecti...

2024-04-05 11:30:00 ET Summary There were 24 new analysts in March 2024. Gold, Bitcoin, a Bitcoin proxy pair trade, preferred shares, and a SOTP thesis are all covered. We lead off with some of the most discussed articles from last month, with a few that generated over 100 com...

2024-03-25 14:08:26 ET Summary Teva Pharmaceutical is deeply undervalued, trading at a 77% discount per my calculations, and the new CEO's turnaround plan looks promising. Teva is an Israeli pharmaceutical company focused on affordable generic medicine, with a strong presence in N...

2024-02-09 22:17:09 ET Summary David Abrams' 13F portfolio value increased from $3.03B to $3.22B this quarter. Meta Platforms and Teva Pharmaceutical saw stake decreases in Abrams' portfolio. Abrams kept steady positions in Lithia Motors, Asbury Automotive, Alphabet Inc., and ...

2024-01-31 11:50:06 ET Teva Pharmaceutical Industries Limited (TEVA) Q4 2023 Earnings Conference Call January 31, 2024 8:00 am ET Company Participants Richard Francis - President, Chief Executive Officer Eric Hughes - Executive Vice President, Global R&D, Chief M...